This Guideline addresses the clinical and laboratory features of transfusion-related acute lung injury (TRALI), as well as its management. TRALI is a life-threatening complication of transfusion that is clinically indistinguishable from the acute respiratory distress syndrome (ARDS), but which has a more favorable prognosis. Nevertheless, in the developed nations, it is the second or third most common cause of death from transfusion.
Developed for the Scientific Section Coordinating Committee by Mark A. Popovsky, MD
(AABB, 2003, 5 pages, Digital, ISBN 978-1-56395-352-1)